Development, implementation and evaluation of a technology-based fall prevention program for community-dwelling older adults

Organizational Data

DRKS-ID:
DRKS00025897
Recruitment Status:
Recruiting complete, study continuing
Date of registration in DRKS:
2021-08-16
Last update in DRKS:
2023-09-25
Registration type:
Prospective

Acronym/abbreviation of the study

For more balance and muscle strength

URL of the study

No Entry

Brief summary in lay language

This study investigates the effects of a novel technology-based fall prevention program and a following home exercise program to reduce the individual fall risk of elderly people at risk of falling. For this purpose, a novel training device ("hunova") of the company Movendo Technology is used to determine the fall risk of the subjects. Based on the subjects fall risk, an individual fall prevention program is developed. The fall prevention programm aims to reduce the fall rate and fall risks through balance and strength exercises. During the training intervention, the difficulty of the exercises will be increased. In addition, the feasibility, user experience and satisfaction of the fall prevention programs will be investigated.

Brief summary in scientific language

The primary outcome of this randomized controlled trial (RCT) is to investigate the effects of a technology-based fall prevention program and a following home exercise program with older people at risk of falling on the number of falls and number of fallers. Therefore, a novel technology-based training device ("hunova") from Movendo Technology is used, which includes balance and strength exercises. During the training intervention, the difficulty of the exercises will be increased. Secondary outcomes are fall-releated risk factors (Silver Index, Subindexes, Timed-up-and-go). Additionally, the feasibility (training diary, TLX, USE, UEQ, feedback questionnaires) of the fall prevention programs will be investigated. The study design refers to a longitudinal design with four measurement time points. To ensure participation in the fall prevention programs, exclusion criteria were defined with regard to physical constitution and acute and chronic diseases.

Health condition or problem studied

Free text:
Fall prevention
Healthy volunteers:
Yes

Interventions, Observational Groups

Arm 1:
Longitudinal design with four measurement time points: T0 before the start of the technology-based fall prevention program, T1 after the end of the technology-based fall prevention program with the hunova device, T2 after the end of the home training program, T3 follow-up measurement, 12 months after T2. In total, the training period of the intervention group consists of 2*24 training sessions with a training frequency of two planned training sessions (à 30 minutes) per week. The intervention period of the technology-based fall prevention program depends on the progress of the completed 24 training sessions. Due to the defined training frequency of two training sessions per week, there is a minimum of 12 weeks of the technology-based fall prevention program. If training sessions are cancelled, the intervention period is limited to a maximum of 16 weeks. Identical to the intervention period of the technology-based fall prevention program, the period of the home training program is then defined individually for each subject.
Arm 2:
Longitudinal design with four measurement time points: Subjects in the control group will receive the identical measurements: T0 before the start of the study, T1 after 16 weeks of T0, T2 after 16 weeks of T1, T3 follow-up measurement after 12 months of T2. Subjects in the control group are not provided with any interventions. They are supposed to maintain their usual activities. At the end of the study, the subjects of the control group will be invited to the Hunova training, which will be finalized based on the study results.

Endpoints

Primary outcome:
Primary outcomes are the effects of a new technology-based fall prevention program and following home training program with community dwelling older people at risk of falling on the number of falls and the number of fallers.
Secondary outcome:
Seconday outcomes refer to the effects on fall-related risk factors (Silver Index, subindexes, number of deficient training areas, timed-up-and-go). Additionally, the feasibility of fall prevention programs will be examined with questionnaires (feedback questionnaires, Task Load Index, Usefulness, Satisfaction and Ease of Use, User Experience Questionnaire, training diary).

Study Design

Purpose:
Prevention
Allocation:
Randomized controlled study
Control:
  • Control group receives no treatment
Phase:
II
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
No
Assignment:
Parallel
Sequence generation:
No Entry
Who is blinded:
No Entry

Recruitment

Recruitment Status:
Recruiting complete, study continuing
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Multicenter study
Recruitment location(s):
  • Other Therapiezentrum Düsseldorf, Köln, Bonn, Bremen

Recruitment period and number of participants

Planned study start date:
2021-09-01
Actual study start date:
2021-09-01
Planned study completion date:
No Entry
Actual Study Completion Date:
No Entry
Target Sample Size:
235
Final Sample Size:
293

Inclusion Criteria

Sex:
All
Minimum Age:
65 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
Community-dwelling older people aged 65 years and older, who are able to walk a distance of more than 6 meters without aids, will be included in the study. Furthermore, an increased risk of falling (Silver Index > 40%) is defined as an inclusion criterion, which is determined by the hunova device (Silver Index, parameter for measuring the risk of falling).

Exclusion Criteria

In order to ensure participation in the fall prevention programs exclusion criteria were defined with regard to physical constitution and acute and chronic diseases. The exclusion criteria are checked with health questionnaires before the first measurement (see appendix).

Addresses

Primary Sponsor

Address:
Generali Health Solutions GmbH
Hansaring 40-50
50670 Köln
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry
Investigator Sponsored/Initiated Trial (IST/IIT):
No

Contact for Scientific Queries

Address:
Deutsche Sporthochschule Köln, Institut für Bewegungs- und Sportgerontologie
Dr. Tobias Morat
Am Sportpark Müngersdorf 6
50933 Köln
Germany
Telephone:
0221 4982 6129
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Contact for Public Queries

Address:
Deutsche Sporthochschule Köln, Institut für Bewegungs- und Sportgerontologie
Institut für Bewegungs- und Sportgerontologie -
Am Sportpark Müngersdorf 6
50933 Köln
Germany
Telephone:
0221 4982 6149
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Principal Investigator

Address:
Deutsche Sporthochschule Köln, Institut für Bewegungs- und Sportgerontologie
Dr. Tobias Morat
Am Sportpark Müngersdorf 6
50933 Köln
Germany
Telephone:
0221 4982 6129
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Sources of Monetary or Material Support

Commercial (pharmaceutical industry, medical engineering industry, etc.)

Address:
Generali Health Solutions GmbH
Hansaring 40-50
50670 Köln
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Ethics Committee

Address Ethics Committee

Address:
Ethikkommission der Deutschen Sporthochschule Köln
Am Sportpark Müngersdorf 6
50933 Köln
Germany
Telephone:
(+49)221-49823810
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2021-06-26
Ethics committee number:
104/2021
Vote of the Ethics Committee:
Approved
Date of the vote:
2021-07-13

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry